JGC
MDT icon

J. Goldman & Co’s Medtronic MDT Stock Holding History

J. Goldman & Co’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,392
Closed -$207K – 840
2026
Q1 		$207K Buy
+2,392
New +$229K 0.01% 598
2016
Q2 		– Sell
-137,800
Closed -$10.3M – 385
2016
Q1 		$10.3M Buy
+137,800
New +$10.4M 0.64% 43
2015
Q4 		– Sell
-101,902
Closed -$6.82M – 271
2015
Q3 		$6.82M Buy
+101,902
New +$7.51M 0.58% 52
2014
Q4 		– Sell
-165,000
Closed -$11.5M – 247
2014
Q3 		$10.2M Buy
+165,000
New +$10.5M 0.62% 41
2014
Q1 		– Sell
-221,000
Closed -$12.7M – 271
2013
Q4 		$12.7M Buy
221,000
+201,000
+1,005% +$11.4M 1.59% 9
2013
Q3 		$1.06M Buy
+20,000
New +$1.08M 0.1% 190

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

J. Goldman & Co's MDT Position: Q2 2026 in Review

J. Goldman & Co sold out of Medtronic (MDT) in Q2 2026, closing a stake of 2,392 shares — an estimated $207K sold.

J. Goldman & Co first reported a position in MDT in Q3 2013 and held it in 6 quarters. The position peaked at $12.7M in Q4 2013. 2,135 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • J. Goldman & Co reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • J. Goldman & Co sold 2,392 Medtronic shares in Q2 2026, an estimated $207K.
  • J. Goldman & Co first reported a position in Medtronic in Q3 2013 and held it in 6 quarters.
  • J. Goldman & Co's Medtronic position peaked at $12.7M in Q4 2013.
  • 2,135 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on J. Goldman & Co's 13F filing for Q2 2026, filed 14 Aug 2026.